Comparison of the Pharmacokinetics of STS101, an Intranasal Dry Powder Formulation of Dihydroergotamine, with Other Intranasal, Injectable, and Oral Inhaled DHE Formulations
Presented September 2019 at IHC 2019, the 19th Congress of the International Headache Society.
« Back